425: Strive, Semler Scientific Merger Update & Risks

Strive, Inc. reposted a communication regarding its proposed business combination with Semler Scientific, Inc., emphasizing forward-looking statements and associated risks.

Summary

• Strive, Inc. (Strive) reposted a communication on X.com by its Chief Marketing Officer, Arshia Sarkhani, on November 10, 2025.
• The communication pertains to Strive's proposed business combination with Semler Scientific, Inc. (Semler Scientific).
• It includes a cautionary statement regarding forward-looking statements, highlighting inherent risks and uncertainties associated with the merger.
• Investors and stockholders are urged to review the Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus for comprehensive details on the proposed transaction.
• The document identifies Strive, Semler Scientific, and certain directors, executive officers, and employees as potential participants in the solicitation of proxies from Semler Scientific stockholders.
• The communication explicitly states it does not constitute an offer to sell or a solicitation of an offer to buy any securities.

Sentiment

Score: 5

Explanation: The filing is a procedural update for a proposed merger, heavily weighted with cautionary forward-looking statements and a comprehensive list of risks, leading to a neutral sentiment regarding the filing itself, despite the underlying transaction's potential.

Positives

• The proposed transaction is anticipated to yield strategic and financial benefits, including an expected positive impact on the combined company's future financial performance.
• The merger is expected to result in anticipated cost savings and strategic gains.

Negatives

• The integration of the two companies may prove more difficult, time-consuming, or costly than initially expected.
• The proposed transaction could be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.

Risks

• The merger agreement could be terminated due to the occurrence of certain events, changes, or circumstances.
• The proposed transaction may not close as expected or at all if closing conditions are not met on a timely basis.
• The outcome of any legal proceedings instituted against Strive, Semler Scientific, or the combined company could be adverse.
• Anticipated benefits, including cost savings and strategic gains, may not be realized when expected or at all.
• Risks are associated with changes in, or problems arising from, the implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, laws, and regulations, and their enforcement could negatively impact the combined company.
• Dilution may occur for existing shareholders due to Strive's issuance of additional shares of its Class A common stock.
• Potential adverse reactions from customers or changes to business or employee relationships could arise from the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price before closing could occur.
• Other unknown or unpredictable factors could harm the results of Strive, Semler Scientific, or the combined company.

Future Outlook

The outlook and expectations of Strive and Semler Scientific regarding the proposed transaction, including its strategic and financial benefits, the expected impact on the combined company's future financial performance, the timing of the closing, and the ability to successfully integrate the combined businesses, are considered forward-looking statements.

Industry Context

The filing focuses on the specific business combination between Strive and Semler Scientific and does not provide broader industry trend analysis.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a significant risk factor.

Stakeholder Impact

• There is a potential for adverse reactions from Strive's or Semler Scientific's customers.
• Changes to business or employee relationships could result from the announcement or completion of the proposed transaction.

Next Steps

• Strive and Semler Scientific may file additional relevant documents concerning the proposed transaction with the SEC.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available, along with any other relevant documents filed with the SEC.

Key Dates

Keywords

Strive, Semler Scientific, Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Corporate Governance, Bitcoin Treasury, Digital Assets